Which CoHeReNt members are involved?
Jaroslav Rosenberger (email@example.com)
Peter Kolarčik, Andrea Madarasová Gecková, Eva Čepová, Ivana Skoumalová, Andrej Belák, Zuzana Dankulincová Veselská, Daniela Husárová
What does the team do?
Research of this team aim to explore how to eliminate health inequalities caused by chronic disease and promotes quality of life in patients with chronic disease.We focus on health literacy profiles typical for selected chronic diseases and use of these profiles to. The revealed findings are expected to let us identify the key areas for targeting interventions that would increase clients’ health literacy in the critical domains and improve responsiveness of the healthcare providers with aim to increase efficiency of chronic disease management both among clients and healthcare providers.
What methods does the team use?
The team uses cross-sectional as well as longitudinal design using questionnaires and variety of biomedical indicators of health status are being used.
What are the team’s most remarkable projects?
Our team participates in several research projects based on collaboration between University of Groningen, Netherlands and Pavol Jozef Šafárik University in Košice, Slovak republic within research program Chronic Disease. Focus in on biomedical and psychosocial factors related to functional status and well-being of patients with multiple sclerosis, Parkinson’s disease; development in functional status and quality of life among children with renal disease; perceived health status in patients with chronic kidney failure and after kidney transplantation; functional status and quality of life in rheumatoid arthritis patients; social class and its impact on patient’s functional status and recovery process after cardiological or cardiosurgical intervention; coronary heart disease from a psychosocial perspective: socioeconomic and ethnic inequalities among Slovak patients.
This work as a part of the project “Utilization of the health literacy profile to improve the management of chronic diseases” was supported by the Research and Development Support Agency under Contract No. APVV-16-0490.